Published
US government health regulators have approved the first medication called aducanumab to treat Alzheimer’s disease in nearly two decades.
Its makers say it reduces fatty plaque in the brain which is the main reason for mental decline.
But independent experts say more studies on the drug need to be done as results are so far inconclusive.
Al Jazeera’s Rob Reynolds reports.
- Follow us on Twitter: https://twitter.com/AJEnglish/
- Find us on Facebook: https://www.facebook.com/aljazeera/
- Check our website: https://www.aljazeera.com/
#Alzheimers #Aducanumab #Biogen
Its makers say it reduces fatty plaque in the brain which is the main reason for mental decline.
But independent experts say more studies on the drug need to be done as results are so far inconclusive.
Al Jazeera’s Rob Reynolds reports.
- Follow us on Twitter: https://twitter.com/AJEnglish/
- Find us on Facebook: https://www.facebook.com/aljazeera/
- Check our website: https://www.aljazeera.com/
#Alzheimers #Aducanumab #Biogen
- Category
- World
- Tags
- Aducanumab, Aljazeera, Alzheimer disease
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
06:45
US approves first new Alzheimer's drug in 20 years - BBC News
-
01:33
Breakthrough or risk? FDA approves Alzheimer's drug
-
04:42
US FDA approves 1st new Alzheimer’s drug in nearly 20 years
-
16:02
What’s The Controversy Behind Biogen’s Alzheimer’s Drug?
-
06:00
Why the FDA approved a controversial Alzheimer's drug
-
04:04
New Alzheimer's drug 'opens door for more funding'
-
1:35:01
ABC News Prime: FDA approves Alzheimer's drug; Ukraine counteroffensive; "Joy Ride" cast on new film
-
02:54
How will this new drug change Alzheimer's treatment?
-
01:55
U.S. FDA approves experimental Alzheimer's drug
-
03:35
How will this new drug impact Alzheimer’s disease patients?
-
02:48
'This is not a cure' -doctor on Alzheimer's drug
-
03:31
FDA approves controversial Biogen Alzheimer's drug | DW News
-
01:32
Biogen CEO to step down after Alzheimer's drug snags
-
01:35
US government approves Alzheimer’s drug to slow cognitive decline
-
03:53
New drug can slow the development of Alzheimer's
-
06:10
The Science Behind Aduhelm, a Controversial New Alzheimer’s Drug | WSJ
-
02:19
New Alzheimer's drug approved by US regulator
-
02:43
New Alzheimer's drug is first 'to target the root cause'
-
04:50
FDA approves new drug to slow progression of Alzheimer's
-
02:17
FDA approves new treatment for Alzheimer’s disease | WNT
-
12:34
An Alzheimer’s Drug That Doesn’t Treat Alzheimer’s?
-
01:18
FDA grants accelerated approval to Alzheimer's drug
Loading...